Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.3000
+0.0260 (9.49%)
May 22, 2026, 4:00 PM EST

Bio Essence Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.381.90.32-0.620.89
Revenue Growth (YoY)
586.42%485.78%---30.00%-7.38%
Cost of Revenue
0.650.470.11-0.290.59
Gross Profit
1.731.430.22-0.330.3
Selling, General & Admin
0.410.530.680.350.841.15
Operating Expenses
0.410.530.680.350.841.16
Operating Income
1.320.9-0.46-0.35-0.51-0.86
Interest Expense
-0-0-0-0-0.01-0.04
Other Non Operating Income (Expenses)
-0-0-0.05-0.06-00.01
EBT Excluding Unusual Items
1.320.9-0.51-0.4-0.53-0.89
Asset Writedown
---1.05---
Other Unusual Items
-----0.24
Pretax Income
1.320.9-1.56-0.4-0.53-0.64
Income Tax Expense
0.0100000
Earnings From Continuing Operations
1.310.9-1.57-0.4-0.53-0.65
Earnings From Discontinued Operations
--0.26-0.57-0.28-
Net Income
1.310.9-1.31-0.97-0.81-0.65
Net Income to Common
1.310.9-1.31-0.97-0.81-0.65
Shares Outstanding (Basic)
403838343333
Shares Outstanding (Diluted)
403838343333
Shares Change (YoY)
4.57%-11.94%2.86%--0.08%
EPS (Basic)
0.030.02-0.03-0.03-0.02-0.02
EPS (Diluted)
0.030.02-0.03-0.03-0.02-0.02
Free Cash Flow
1.181.570.62-1.03-0.71-1.41
Free Cash Flow Per Share
0.030.040.02-0.03-0.02-0.04
Gross Margin
72.69%75.28%67.01%-52.82%33.60%
Operating Margin
55.60%47.43%-141.83%--82.23%-96.57%
Profit Margin
55.02%47.23%-404.02%--130.26%-72.92%
Free Cash Flow Margin
49.83%82.73%192.59%--113.74%-159.19%
EBITDA
1.320.9-0.46-0.34-0.5-0.82
EBITDA Margin
55.61%47.44%-141.47%--79.90%-92.54%
D&A For EBITDA
00000.010.04
EBIT
1.320.9-0.46-0.35-0.51-0.86
EBIT Margin
55.60%47.43%-141.83%--82.23%-96.57%
Effective Tax Rate
0.81%0.09%----
Revenue as Reported
2.381.90.32-0.620.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.